tirzepatide beginner dose Dosing for Weight Loss in Units Tirzepatide Dosage Chart & Dosing

Explore the broader landscape

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus in adults (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

If Trulicity were to be considered despite this guidance, this would be an off-label use requiring specialist oversight and careful monitoring of both mother and infant

This makes sense because the drugs work by modulating gut function

Retatrutide is a triple-agonist (GLP-1, GIP, and glucagon receptor) that has shown even more dramatic weight loss results in early trials